New scan seeks to sharpen prostate cancer detection
NCT ID NCT07468708
Summary
This early-stage study is testing a new radioactive tracer called ⁶⁸Ga-FC516 for use in PET/CT scans. The goal is to see if this new agent is safe, where it goes in the body, and if it can help doctors spot prostate cancer tumors as well as or better than existing imaging methods. The study will enroll 30 people, including healthy volunteers and patients with prostate cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The first affiliated hospital of Jinan University
Guangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.